No Data
No Data
Express News | JMP Securities Reiterates Market Outperform on Cytokinetics, Maintains $78 Price Target
Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK) and Canopy Growth (CGC)
Cytokinetics to Participate in June Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that the company is scheduled to participate in the following investor conferences in June:
Cytokinetics Is Maintained at Buy by Truist Securities
Cytokinetics Is Maintained at Buy by Truist Securities
Truist Financial Sticks to Its Buy Rating for Cytokinetics (CYTK)
Express News | Cytokinetics Inc : Truist Securities Cuts Target Price to $70 From $86
No Data